1. Home
  2. AXTI vs WHWK Comparison

AXTI vs WHWK Comparison

Compare AXTI & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTI
  • WHWK
  • Stock Information
  • Founded
  • AXTI 1986
  • WHWK 2007
  • Country
  • AXTI United States
  • WHWK United States
  • Employees
  • AXTI N/A
  • WHWK N/A
  • Industry
  • AXTI Semiconductors
  • WHWK Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXTI Technology
  • WHWK Health Care
  • Exchange
  • AXTI Nasdaq
  • WHWK Nasdaq
  • Market Cap
  • AXTI 94.4M
  • WHWK 82.4M
  • IPO Year
  • AXTI 1998
  • WHWK N/A
  • Fundamental
  • Price
  • AXTI $3.11
  • WHWK $1.82
  • Analyst Decision
  • AXTI Strong Buy
  • WHWK
  • Analyst Count
  • AXTI 4
  • WHWK 0
  • Target Price
  • AXTI $4.60
  • WHWK N/A
  • AVG Volume (30 Days)
  • AXTI 659.6K
  • WHWK 117.1K
  • Earning Date
  • AXTI 10-30-2025
  • WHWK 08-07-2025
  • Dividend Yield
  • AXTI N/A
  • WHWK N/A
  • EPS Growth
  • AXTI N/A
  • WHWK N/A
  • EPS
  • AXTI N/A
  • WHWK N/A
  • Revenue
  • AXTI $86,080,000.00
  • WHWK $21,596,000.00
  • Revenue This Year
  • AXTI N/A
  • WHWK N/A
  • Revenue Next Year
  • AXTI $31.28
  • WHWK N/A
  • P/E Ratio
  • AXTI N/A
  • WHWK N/A
  • Revenue Growth
  • AXTI N/A
  • WHWK N/A
  • 52 Week Low
  • AXTI $1.13
  • WHWK $1.39
  • 52 Week High
  • AXTI $3.29
  • WHWK $3.81
  • Technical
  • Relative Strength Index (RSI)
  • AXTI 65.96
  • WHWK 55.63
  • Support Level
  • AXTI $2.91
  • WHWK $1.76
  • Resistance Level
  • AXTI $2.95
  • WHWK $1.87
  • Average True Range (ATR)
  • AXTI 0.22
  • WHWK 0.07
  • MACD
  • AXTI 0.05
  • WHWK 0.02
  • Stochastic Oscillator
  • AXTI 85.37
  • WHWK 83.33

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About WHWK Whitehawk Therapeutics Inc. Common Stock

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Share on Social Networks: